XJPX
4045
Market cap1.20bUSD
Oct 09, Last price
1,791.00JPY
1D
0.00%
1Q
3.89%
Jan 2017
55.60%
Name
Toagosei Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Toagosei Co., Ltd. engages in the manufacture and sale of chemical and industrial products. It operates through the following segments: Commodity Chemicals, Polymer & Oligomer, Adhesive Material, Performance Chemicals, Plastics, and Others. The Commodity Chemicals segment supplies products used in a wide range of industries including caustic soda, sulfuric acid, industrial gases, and inorganic high-purity chemicals. The Polymer & Oligomer segment provides acrylic acid, acrylic ester, acrylic polymer, polymer flocculants, and UV-Curable Resins. TheAdhesive Material segment includes functional adhesives, amenity care materials, and electronic products. The Plastics segment provides piping equipment, nursing care products, elastomeric compounds, and products for use in environmental preservation systems. The Others segment includes facility construction and repair business, transportation business, research and development of new products, and trading business. The company was founded by Momosuke Fukuzawa in 1933 and is headquartered in Tokyo, Japan.
Key people
Atsushi Tamura
Executive Officer, Manager of Osaka Centre · since 2026
Kazutaka Yamada
Executive Officer, President of Subsidiary · since 2022
Akihiko Matsuda
Executive Officer, President of a Subsidiary · since 2026
Yoshihito Takahashi
Director · since 2024
Masahiko Enomoto
Independent Director · since 2026
Reiko Ishiyama
Independent Director · since 2025
Takashi Kato
Independent Director · since 2023
Yoshiyuki Kobayashi
Independent Director · since 2026
Independent Director · since 2025
Toshiyuki Teramoto
Independent Director · since 2024
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||